# APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials

> **NCT06868355** · — · RECRUITING · sponsor: **University of Manchester** · enrollment: 40 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** No intervention (observational study)

## Key facts

- **NCT ID:** NCT06868355
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-28
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06868355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06868355, "APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06868355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*